Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks
Seeking Alpha News (Fri, 19-Apr 3:00 PM ET)
Procter & Gambles misses organic sales expectations as pricing benefit fades
Seeking Alpha News (Fri, 19-Apr 7:17 AM ET)
Procter & Gamble misses organic sales expectations as pricing benefit fades
Seeking Alpha News (Fri, 19-Apr 7:17 AM ET)
RBC Capital Sticks to Its Hold Rating for Colgate-Palmolive (CL)
TipRanks (Thu, 18-Apr 9:46 PM ET)
Colgate-Palmolive Webcasts 2024 First Quarter Earnings Conference Call April 26, 2024 8:30 a.m. ET
Business Wire (Fri, 12-Apr 9:35 AM ET)
Tom's of Maine Launches New Deodorant Line, Encouraging Consumers to Smell Good and Do Good
PRNewswire (Sat, 6-Apr 12:58 AM ET)
Colgate Announces Dividend Increase Effective 2nd Quarter 2024
Business Wire (Thu, 14-Mar 4:35 PM ET)
ZO Skin Health Appoints Industry Veteran Justin Skala as CEO to Continue Strong Growth
PRNewswire (Tue, 12-Mar 1:08 PM ET)
Colgate-Palmolive Webcasts Fireside Chat at the UBS Global Consumer and Retail Conference 2024
Business Wire (Wed, 28-Feb 9:35 AM ET)
Colgate Elects Brian Newman to Board of Directors
Business Wire (Thu, 15-Feb 4:30 PM ET)
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oralcare line, the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International accounts for about 70% of its total sales base, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Colgate-Palmolive Company trades on the NYSE stock market under the symbol CL.
As of April 19, 2024, CL stock price climbed to $87.13 with 5,096,655 million shares trading.
CL has a beta of 0.38, meaning it tends to be less sensitive to market movements. CL has a correlation of 0.10 to the broad based SPY ETF.
CL has a market cap of $71.62 billion. This is considered a Large Cap stock.
Last quarter Colgate-Palmolive Company reported $5 billion in Revenue and $.87 earnings per share. This beat revenue expectation by $60 million and exceeded earnings estimates by $.02.
In the last 3 years, CL stock traded as high as $90.37 and as low as $67.62.
The top ETF exchange traded funds that CL belongs to (by Net Assets): VTI, VOO, SPY, IVV, XLP.
CL stock has underperformed the market in the last year with a return of +17.9%, while SPY returned +21.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CL shares. However, CL has outperformed the market in the last 3 month and 2 week periods, returning +9.0% and -0.3%, while SPY returned +4.3% and -3.5%, respectively. This indicates CL has been having a stronger performance recently.
CL support price is $85.56 and resistance is $86.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CL stock will trade within this expected range on the day.